Developments Driving Drug Delivery: PharmTech
February 3, 2021
Rapid growth in biologics and increasing complexity of new compounds are some of the factors driving the development of innovative drug delivery systems and solutions.
In this article with Pharmaceutical Technology, Lynn Allen, Vice-President of Business Development, MedPharm joins other industry experts to unpack the current drug development trends driving demand for new drug delivery systems across the bio/pharma industry – touching on how through the application of in-vitro performance testing models MedPharm has been able to de-risk clinical trials for products targeting skin, eye, and mucosal membrane diseases.
MedPharm is the world’s leading contract provider of topical and transdermal formulation development and manufacturing services. Our experts specialize in reducing risk and accelerating development times for generic and proprietary pharmaceutical customers through cost-effective and industry-leading performance testing models. Well-established as the global leader in dermal and transdermal product development, MedPharm also offers innovative solutions for airway, ophthalmic, otic, ungual, and other topical preparations. With locations in both the US and the UK, MedPharm is the CDMO of choice for developers around the globe.